ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2215

Evaluation of Left Ventricular Systolic and Diastolic Myocardial Function in Patients with Ankylosing Spondylitis By Speckle-Tracking Echocardiography

Hang Yang1, Yi Zhao1, Yujia Liang2, Wenkai Yan3, Yi Liu4, Lingshu Zhang1 and Tony Marion5, 1Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China, 2Department of Cardiology, West China Hospital, Sichuan University, CHENGDU, China, 3Southern Medical University, GUANGZHOU, China, 4Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Chengdu, China, 5Immunology and Biochemistry University of Tennessee Health Science Center, Memphis, TN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Imaging of Rheumatic Diseases Poster III: Other Modalities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with ankylosing spondylitis (AS) are at increased risk for cardiovascular disease (CVD), although strategies to detect subclinical CVD are poorly characterized. The aim of this study was to assess left ventricular (LV) systolic and diastolic function by speckle tracking echocardiography (STE) to detect subclinical left ventricular dysfunction in patients with AS without known CVD. We also tested if CVD activity in AS was associated with lower LV systolic function independently of traditional cardiovascular risk factors.

Methods: Two-dimensional, Doppler, tissue Doppler, and STE assessments were performed in 44 patients with AS (Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP) ≥1.3), 20 patients with inactive disease (ASDAS-CRP<1.3), and 26 healthy controls. AS diagnoses fulfilled the modified New York criteria. None of the enrolled patients or healthy individuals had known cardiac disease. LV systolic function was assessed by ejection fraction (EF) and global longitudinal strain (GLS). LV diastolic function was assessed by septal e’, lateral e’, left atrial maximum volume index (LAVI), average E/e’ ratio, and peak tricuspid regurgitation velocity.

Results: Mean patient age was 31-35 years with 91-95% males in all groups. The average disease duration for patients with active and inactive AS was 9 years. LV EF was normal in all patients and controls and did not differ between groups (p ≥ 0.43). GLS was significantly reduced in active AS patients compared with inactive AS patients (21.9 ± 2.02 vs 24.4 ± 2.73, p < 0.0001) and controls (21.9 ± 2.02 vs 24.0 ± 2.00, p = 0.0001). In multivariate analyses, active AS and increasing levels of disease activity by ASDAS-CRP score were associated with lower GLS after adjustment for other covariables that included age, sex, body mass index, systolic blood pressure, and disease duration. Septal e’ and lateral e’ were decreased in active AS patients compared with controls (9.30 ± 2.08 vs 10.5 ± 1.78, p = 0.01 and 12.9 ± 2.95 vs 14.9 ± 2.91, p = 0.007), respectively, but not inactive AS patients (p ³ 0.11). LAVI was not significantly higher in active AS patients versus controls or inactive AS patients (p ≥ 0.10). The average E/e’ ratio was higher in active AS patients compared with controls (8.13 ± 1.97 vs 7.25 ± 1.10, p = 0.04) but not inactive AS patients (p = 0.27). GLS, septal e’ and lateral e’, LAVI, and average E/e’ did not differ between inactive AS and controls (p =≥ 0.49). Tricuspid regurgitation did not differ among the three groups, and the velocity was far less than 2.8 m/s generally used as the cut-off for diagnosis of LV diastolic dysfunction.

Conclusion: GLS is significant reduced in Active AS patients compared with Inactive AS patients and healthy controls. Active AS is associated with lower LV systolic myocardial function despite normal LV EF. Patients with Active AS may also have impaired left ventricular diastolic function. Speckle tracking echocardiography may be a useful tool for early detection of impaired LV function in patients with AS. Disease activity in AS was associated with lower LV systolic function independently of traditional cardiovascular risk factors.


Disclosure: H. Yang, None; Y. Zhao, None; Y. Liang, None; W. Yan, None; Y. Liu, None; L. Zhang, None; T. Marion, None.

To cite this abstract in AMA style:

Yang H, Zhao Y, Liang Y, Yan W, Liu Y, Zhang L, Marion T. Evaluation of Left Ventricular Systolic and Diastolic Myocardial Function in Patients with Ankylosing Spondylitis By Speckle-Tracking Echocardiography [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-left-ventricular-systolic-and-diastolic-myocardial-function-in-patients-with-ankylosing-spondylitis-by-speckle-tracking-echocardiography/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-left-ventricular-systolic-and-diastolic-myocardial-function-in-patients-with-ankylosing-spondylitis-by-speckle-tracking-echocardiography/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology